Summary BHCS3003 Antimicrobial therapy, vaccines and resistance
1 view 0 purchase
Course
BHCS3003 Clinical Microbiology (BHCS3003)
Institution
Plymouth University (UOP)
Compiled from lecture notes, this is a condense but detailed summary of antimicrobials, vaccines and antimicrobial resistance so all the information (and more) is available in one place in a logical order, easy to search and use for revision.
Antimicrobial therapy
• Antimicrobials – agent which either kills or stops microbial growth
o Antibiotics
o Antivirals
o Antiparasitic, antimalarials
o Antifungals
• Antibiotics underpin modern medicine
o Given as prophylactic to cancer patients
o Surgery
o Bites wounds
o Minor ailments – e.g., ingrown nail
o Diabetes
o Complications in pregnancy, UTIs etc
• Infection prevention required
o Behavioural changes when prescribing, increased stewardship
o Novel solutions, vaccines, phage therapies
o Surveillance – incidence rates = accurate statistics
o Engage and educate the public
• Bacteria exchange of genetic material
o Transformation
▪ Bacteria pick up genes on plasmids in environment
▪ Seen with resistant genes of Klebsiella in water
o Transduction
▪ Phage-infected bacterial cell releases phage carrying gene which is then inserted into
another bacterial cell
▪ When using phage therapy, don’t know the genetic changes that occur in the
bacteria due to the phage
▪ There is no monitoring of phage-infected bacteria and their genetic alterations
currently
o Conjugation – horizontal gene transfer via pili
• Discovery of antibiotics
o Penicillin G
▪ 1929 Alexander Fleming characterised antibiotic from fungus Penicillum
chysogenum/notatum)
▪ Beta-lactam penicillin G
▪ 1939 Florey and Chain developed process for large scale production of penicillin
▪ Used on soldiers during WW2
▪ General use in 1945
▪ Fleming, Florey, and Chain warned at the start to building of resistance in bacteria to
penicillin by exposing bacteria to sub-lethal concentrations
o ‘Golden era’ of antibiotic discovery 1940s-1960s
▪ 1940s – penicillin, gramicidin, neomycin, streptomycin, cephalosporin
▪ 1950s – chloramphenicol, chlortetracycline, polymyxin, erythromycin, vancomycin,
virginiamycin
▪ 1960s – rifamycin
o Last antibiotic discovered was daptomycin in 2003
o Antibiotics of golden era were overmined, overprescribed and overused (no stewardship or
preservation) = resistance
o Money needed at every step of antibiotic discovery pipeline – very expensive process
o No progression on diagnostics – still use agar plates (created in early 1940s)
• Antibiotic mode of action
o Inhibition of protein synthesis
, ▪ Aminoglycosides – streptomycin
▪ Chloramphenicol
▪ Macrolides
▪ Tetracyclines
▪ Oxazolidinones – linezolid
▪ Streptogramins – pristingamycin
o Inhibition of nucleic acid (DNA) synthesis
▪ Quinolines – ciprofloxacin
o Inhibition of cell wall synthesis
▪ Beta-lactams – penicillin, carbapenem
▪ Glycopeptides – vancomycin (creates pores in crosslink between NAG and NAM)
o Disruption of cell membrane functions
▪ Lipopeptides – daptomycin
o Inhibition of RNA synthesis
▪ Ansamycins – rifamycin
o Prevent growth/multiplication
▪ Sulphonamides – sulphanilamide
• Antibiotics used in combination to attack multiple bacterial processes
o Need a balance between high concentration of antibiotics to kill bacteria but without long
term effects to patient – many doctors will choose a patient to live with kidney/liver
damage than die from infection
• Broad spectrum antibiotics effective against a wide range of bacteria
• Narrow spectrum antibiotics effective against specific bacteria
• Bacteriostatic antibiotics inhibit bacterial growth – e.g., beta-lactams, glycopeptides, colistin
• Bactericidal antibiotics kill bacteria – e.g., macrolides, tetracyclines, chloramphenicol
• Antibiotic resistance on the rise in a lot of antibiotics 0 occurs when bacteria change in response to
use of antibiotics, they evolve to survive
• Human impact
o A global issue
o 10million deaths by AMR resistance by 2050 – more than cancer and diabetes combined
o Burden of infectious comparable to influenza, TB, and HIV/AIDs combined
o Estimated £1 trillion of GDP lost due to efforts combating AMR in patients (without
appropriate R&D) – socioeconomic issue
o Should have an international AMR meeting (like COP with global warming)
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller AH1984. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $12.15. You're not tied to anything after your purchase.
